A recall is the firm's action; the class is FDA's call

The word “recall” sounds like something done to a company — an order handed down, a device pulled by the agency. For medical devices it is almost always the reverse: the firm decides to act, initiates the recall, and notifies its customers, often before FDA has classified anything. The agency's role comes at a different point and answers a different question. Confusing the two — who acts, and who grades the hazard — is how a recall procedure ends up waiting for permission that was never required, or assigning itself a severity that was never its to assign.

The mechanics live in 21 CFR Part 7, Subpart C, and they divide the work cleanly. The firm removes or corrects a marketed product that violates the law or is defective. FDA evaluates the hazard and assigns a class. Neither party does the other's job.

The firm acts first

A device recall is, in the ordinary case, a voluntary action: the manufacturer or distributor removes the product from the market or corrects it in place, on its own initiative or at FDA's request. It does not wait for an order, because for most recalls no order exists — the firm's own decision to act is the recall. FDA does hold a separate mandatory-recall authority for devices, under section 518(e) of the Federal Food, Drug, and Cosmetic Act and its implementing regulation, but that is a distinct and rarely used power reserved for situations that meet a high bar. Reading every recall as FDA-compelled inverts the normal sequence and builds a procedure that waits for a trigger that isn't coming.

The class is a hazard judgment, and FDA makes it

Once a recall is under way, FDA performs a health hazard evaluation and assigns a classification under 21 CFR 7.41. The three classes are defined by the degree of hazard, not by the firm's estimate of it: Class I where there is a reasonable probability that use will cause serious adverse health consequences or death; Class II where use may cause temporary or medically reversible consequences, or where serious harm is remote; Class III where use is not likely to cause adverse health consequences. The firm supplies the information; the agency makes the call. A recall record that fills in its own class as if it were self-evident has claimed a determination the regulation assigns to FDA.

A recall is not a market withdrawal or a stock recovery

Part 7 defines neighboring actions that are deliberately not recalls. A market withdrawal is a firm's removal or correction of a product for a minor issue that would not be subject to legal action by FDA — a normal stock rotation, a cosmetic problem with no violation. A stock recovery is a correction or removal of product that has not yet left the firm's own control. The distinctions matter because they decide reporting and public-notice consequences: calling a genuine recall a “withdrawal” understates it, and calling routine housekeeping a “recall” triggers obligations that were never owed. The classification of the action starts with naming the action correctly.

The recall is not the correction-and-removal report

The most common structural error is folding two separate duties into one. Conducting a recall under Part 7 is one obligation. Reporting a correction or removal to FDA under 21 CFR Part 806 is another, with its own trigger and its own timeline, and the two do not stand in for each other. The 806 record decides whether a correction or removal must be reported; the Part 7 recall governs how the action itself is carried out and classified. A firm can owe an 806 report without the action rising to a formal recall, and a recall does not discharge the 806 reporting duty just because the customers were notified. This is the same separation-of-duties logic that keeps a field safety notice reporting the action rather than the incident — each instrument answers one question, and collapsing them loses one of the answers.

What the procedure has to keep straight

A recall procedure that holds up separates the firm's decision to act from FDA's classification of the hazard, distinguishes a recall from a withdrawal or stock recovery before either starts, and carries the 806 reporting decision as its own step rather than an afterthought of the recall. A recall-readiness checklist built to keep those lines distinct is previewed in the launch catalog. If your program runs recalls to a structure this one is missing, the shelf takes that correction directly.